Lipid microspheres loaded with antigenic membrane proteins of the Leishmania amazonensis as a potential biotechnology application.
Lipid microspheres (LM) are excellent drug delivery or vaccines adjuvant systems and are relatively stable. The aim of this work is to develop and characterize a system that is able to encapsulate and present antigenic membrane proteins from Leishmania amazonensis. Membrane proteins are important for vaccine's formulation because these proteins come in contact with the host cell first, triggering the cell mediated immune response. This is a useful tool to avoid or inactivate the parasite invasion. The LM are constituted by soybean oil (SO), dipalmitoylphosphatidilcholine (DPPC), cholesterol and solubilized protein extract (SPE). The particles formed presented an average diameter of 200 nm, low polydispersion and good stability for a period of 30 days, according to dynamic light scattering assays. Isopycnic density gradient centrifugation of LM-protein showed that proteins and lipids floated in the sucrose gradient (5-50%w/v) suggesting that the LM-protein preparation was homogeneous and that the proteins are interacting with the system. The results show that 85% of SPE proteins were encapsulated in the LM. Studies of cellular viability of murine peritoneal macrophages show that our system does not present cytotoxic effect for the macrophages and still stimulates their NO production (which makes its application as a vaccine adjuvant possible). LM-protein loaded with antigenic membrane proteins from L. amazonensis seems to be a promising vaccine system for immunization against leishmaniasis.
Santos
Luiz E R
LE
Depto. Química, Faculdade de Filosofia Ciências e Letras de Ribeirão Preto (FFCLRP), Universidade de São Paulo (USP), São Paulo, Brazil.
Colhone
Marcelle C
MC
Daghastanli
Katia R P
KR
Stabeli
Rodrigo G
RG
Silva-Jardim
Izaltina
I
Ciancaglini
Pietro
P
D000818:Animals; D000953:Antigens, Protozoan / Q000008:administration & dosage* / Q000276:immunology; D002470:Cell Survival; D002478:Cells, Cultured; D005260:Female; D007891:Leishmania / Q000276:immunology*; D008055:Lipids / Q000737:chemistry*; D008565:Membrane Proteins / Q000008:administration & dosage / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008863:Microspheres; D015800:Protozoan Proteins / Q000008:administration & dosage* / Q000276:immunology
D000953:Antigens, Protozoan; D008055:Lipids; D008565:Membrane Proteins; D015800:Protozoan Proteins